News
A new minimally invasive technique for fixation of an intraocular lens (IOL) was presented at two recent retina conferences. At the Retina World Congress in…
Read More
During the run-up to the launch of Shire’s dry eye drug Xiidra (lifitegrast), it seemed as though everyone was wondering what kind of threat –…
Read MoreOIS co-chair Gil Kliman, MD, managing director of InterWest Partners, opened last week’s OIS@ASCRS with a rousing look at innovation in ophthalmology. “I’ve never been…
Read MoreNearly 600 people packed the ballroom at the Sheraton Grand Los Angeles to make yesterday’s OIS@ASCRS the largest to date. Event co-chairs Emmett Cunningham Jr.,…
Read More
In October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…
Read More
FDA Green Lights Allergan’s Tear Neurostimulator Allergan has been granted marketing authorization from the FDA for its TrueTear Intranasal Tear Neurostimulator. This is the only FDA-approved…
Read More
Stanford start-up Oculeve’s fairy tale story finally has a happy ending penned – at least in part – by its acquirer Allergan. On April 25th, Allergan…
Read More
Coming off word that the Phase I/IIa clinical trial of its novel anti-VEGF candidate for treatment of age-related macular degeneration exceeded expectations, along with positive…
Read More
Soon-to-be FDA commissioner, Scott Gottlieb, MD, is well positioned to understand where the medtech and biotech communities are coming from. He’s been a partner at…
Read More
Medical marijuana has quickly gained acceptance as a viable treatment for a variety of health conditions, such as the side effects of chemotherapy, the neurodegenerative…
Read More
In October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…
Read More
Ora Retained to Develop Cannabinoids for Eye Disease Ora Inc., a global contract research organization that specializes in ophthalmology, took the plunge into medical marijuana…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")